Journal
CLINICAL INFECTIOUS DISEASES
Volume 74, Issue 11, Pages 2053-2056Publisher
OXFORD UNIV PRESS INC
DOI: 10.1093/cid/ciab762
Keywords
COVID-19; E484K; L452R; B; 1; 351; genomic surveillance
Categories
Funding
- National Institutes of Health Intramural Research Program
Ask authors/readers for more resources
A study in Maryland found that between January and May 2021, there was a higher prevalence of SARS-CoV-2 viruses carrying the spike protein mutation E484K among individuals infected after full vaccination against COVID-19.
Among 9048 people infected with SARS-CoV-2 between January and May 2021 in Maryland, in regression-adjusted analysis, SARS-CoV-2 viruses carrying the spike protein mutation E484K were disproportionately prevalent among persons infected after full vaccination against COVID-19 compared with infected persons who were not fully vaccinated (aOR, 1.96; 95% CI: 1.36-2.83).
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
